Indian Journal of Ophthalmology

REVIEW ARTICLE
Year
: 2017  |  Volume : 65  |  Issue : 9  |  Page : 787--796

Recent advances in corneal collagen cross-linking


Gitansha Shreyas Sachdev1, Mahipal Sachdev2 
1 Dr. Gitansha Shreyas Sachdev, The Eye Foundation, Coimbatore, India
2 Centre for Sight, New Delhi, India

Correspondence Address:
Mahipal Sachdev
Centre for Sight, B-5/24, Safdarjung Enclave, New Delhi - 110 029
India

Corneal collagen cross-linking has become the preferred modality of treatment for corneal ectasia since its inception in late 1990s. Numerous studies have demonstrated the safety and efficacy of the conventional protocol. Our understanding of the cross-linking process is ever evolving, with its wide implications in the form of accelerated and pulsed protocols. Newer advancements in technology include various riboflavin formulations and the ability to deliver higher fluence protocols with customised irradiation patterns. A greater degree of customisation is likely the path forward, which will aim at achieving refractive improvements along with disease stability. The use of cross-linking for myopic correction is another avenue under exploration. Combination of half fluence cross-linking with refractive correction for high errors to prevent post LASIK regression is gaining interest. This review aims to highlight the various advancements in the cross-linking technology and its clinical applications.


How to cite this article:
Sachdev GS, Sachdev M. Recent advances in corneal collagen cross-linking.Indian J Ophthalmol 2017;65:787-796


How to cite this URL:
Sachdev GS, Sachdev M. Recent advances in corneal collagen cross-linking. Indian J Ophthalmol [serial online] 2017 [cited 2024 Mar 29 ];65:787-796
Available from: https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2017;volume=65;issue=9;spage=787;epage=796;aulast=Sachdev;type=0